278 related articles for article (PubMed ID: 23775973)
21. Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication.
Weiss GJ; Davis RB
PeerJ; 2019; 7():e6423. PubMed ID: 30775185
[TBL] [Abstract][Full Text] [Related]
22. Brazilian abstracts presented at the American Urological Association annual meetings: contribution, publication rates, and comparison with oncology abstracts.
Arap MA; Reis RB; Torricelli FC; Masson AL; Saad ED
Int Braz J Urol; 2014; 40(6):730-7. PubMed ID: 25615241
[TBL] [Abstract][Full Text] [Related]
23. Conflicts of interest ethics: silencing expertise in the development of international clinical practice guidelines.
Jones DJ; Barkun AN; Lu Y; Enns R; Sinclair P; Martel M; Gralnek I; Bardou M; Kuipers EJ; Sung J;
Ann Intern Med; 2012 Jun; 156(11):809-16, W-283. PubMed ID: 22665816
[TBL] [Abstract][Full Text] [Related]
24. Financial conflicts of interest of physicians followed by oncology journals on Twitter.
Betts C; Kakkilaya A; Vasireddy S; Arora N; Prasad V; Powell K
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14137-14144. PubMed ID: 37552310
[TBL] [Abstract][Full Text] [Related]
25. Discrepancies between author- and industry-reported disclosures of financial relationships at an annual gynecologic oncology research meeting.
Guo XM; Cowan M; Folsom S; Ehimiaghe E; Persenaire C; Barber EL; Tanner EJ
Gynecol Oncol; 2021 Jan; 160(1):260-264. PubMed ID: 33187761
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Drug Trials With Financial Conflict of Interests on the Meta-analyses: A Meta-epidemiological Study.
Zhang N; Yan P; Zhao H; Feng L; Chu X; Li J; Chen N; Yang K; Liu X
Int J Health Policy Manag; 2022 Oct; 11(10):2038-2045. PubMed ID: 34923810
[TBL] [Abstract][Full Text] [Related]
27. Publication rates of podium versus poster presentations at the American Orthopaedic Society for Sports Medicine meetings: 2006-2010.
Kinsella SD; Menge TJ; Anderson AF; Spindler KP
Am J Sports Med; 2015 May; 43(5):1255-9. PubMed ID: 25769534
[TBL] [Abstract][Full Text] [Related]
28. Quality of reporting according to the CONSORT, STROBE and Timmer instrument at the American Burn Association (ABA) annual meetings 2000 and 2008.
Knobloch K; Yoon U; Rennekampff HO; Vogt PM
BMC Med Res Methodol; 2011 Nov; 11():161. PubMed ID: 22126516
[TBL] [Abstract][Full Text] [Related]
29. Association of author's financial conflict of interest with characteristics and outcome of rheumatoid arthritis randomized controlled trials.
Khan NA; Nguyen CL; Khawar T; Spencer H; Torralba KD
Rheumatology (Oxford); 2019 May; 58(5):776-785. PubMed ID: 30535001
[TBL] [Abstract][Full Text] [Related]
30. Discrepancies in Financial Self-Disclosures and Open Payments Reporting Among Authors of Clinical Oncology Research Studies.
Garrett-Mayer E; Kaltenbaugh MW; Spence R; Bruinooge SS; Hudis CA; Michels D; Schilsky RL
J Clin Oncol; 2020 Feb; 38(5):480-487. PubMed ID: 31815584
[TBL] [Abstract][Full Text] [Related]
31. Oral Presentations Have a Significantly Higher Publication Rate, But Not Impact Factors, Than Poster Presentations at the International Society for Study of Lumbar Spine meeting: Review of 1126 Abstracts From 2010 to 2012 Meetings.
Ohtori S; Orita S; Eguchi Y; Aoki Y; Suzuki M; Kubota G; Inage K; Shiga Y; Abe K; Kinoshita H; Inoue M; Kanamoto H; Norimoto M; Umimura T; Furuya T; Masao K; Maki S; Akazawa T; Takahashi K
Spine (Phila Pa 1976); 2018 Oct; 43(19):1347-1354. PubMed ID: 29509653
[TBL] [Abstract][Full Text] [Related]
32. Self-reported financial conflicts of interest during scientific presentations in emergency medicine.
Birkhahn RH; Fromm C; Larabee T; Diercks DB
Acad Emerg Med; 2011 Sep; 18(9):977-80. PubMed ID: 21854482
[TBL] [Abstract][Full Text] [Related]
33. Self-reported Financial Conflict of Interest in Nephrology Clinical Practice Guidelines.
Chengappa M; Herrmann S; Poonacha T
Kidney Int Rep; 2021 Mar; 6(3):768-774. PubMed ID: 33732991
[TBL] [Abstract][Full Text] [Related]
34. American Society of Clinical Oncology 41st annual meeting.
Dillman RO
Expert Opin Biol Ther; 2005 Aug; 5(8):1117-27. PubMed ID: 16050788
[TBL] [Abstract][Full Text] [Related]
35. When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.
Ehrlich O; Wingate L; Heller C; de Melo-Martin I
BMC Med Ethics; 2019 Dec; 20(1):96. PubMed ID: 31847854
[TBL] [Abstract][Full Text] [Related]
36. Editor and peer reviewer financial conflict of interest policies in public health journals.
Ralph A; Petticrew M; Hutchings A
Eur J Public Health; 2020 Dec; 30(6):1230-1232. PubMed ID: 33313818
[TBL] [Abstract][Full Text] [Related]
37. Financial conflicts of interest during meetings of the cardiovascular and renal drugs advisory committee.
Bertolino B; Kinder N; Cooper C; Gray H; Arthur W; Ahlander J; Simpson A; Vassar M
J Osteopath Med; 2022 Sep; 122(9):445-451. PubMed ID: 35447023
[TBL] [Abstract][Full Text] [Related]
38. Consistency of phase III clinical trial abstracts presented at an annual meeting of the American Society of Clinical Oncology compared with their subsequent full-text publications.
Tam VC; Hotte SJ
J Clin Oncol; 2008 May; 26(13):2205-11. PubMed ID: 18445846
[TBL] [Abstract][Full Text] [Related]
39. Don't forget the posters! Quality and content variables associated with accepted abstracts at a national trauma meeting.
Dossett LA; Fox EE; del Junco DJ; Zaydfudim V; Kauffmann R; Shelton J; Wang W; Cioffi WG; Holcomb JB; Cotton BA
J Trauma Acute Care Surg; 2012 May; 72(5):1429-34. PubMed ID: 22673278
[TBL] [Abstract][Full Text] [Related]
40. Pattern of Duplicate Presentations at National Hematology-Oncology Meetings: Influence of the Pharmaceutical Industry.
Ramchandren R; Schiffer CA
J Oncol Pract; 2016 Mar; 12(3):254-9, 252-3. PubMed ID: 26349954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
